Semaglutide:
An average patient taking semaglutide will lose 16% of their body weight—nearly 7x more than with lifestyle interventions alone.
Put another way, the average 200 pound patient can expect to lose 30-35 pounds or more during a course of treatment.
Tirzepatide:
An average patient taking tirzepatide will lose a remarkable 22.5% of their body weight—nearly 10x more than with lifestyle interventions alone.
The average 200 pound patient could expect to lose 45 pounds or more during a course of these medications.
Additional treatment effects:
Patients taking GLP-1 agonists also show dramatic improvements in waist circumference, blood sugar and blood pressure levels, and overall level of physical function—as well as a significant reduction in risk of adverse cardiac events such as heart attack.